Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?

This publication has 41 references indexed in Scilit:

• Explanatory and pragmatic attitudes in therapeutical trials
  Published by Elsevier ,2004
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results
  Osteoarthritis and Cartilage, 2002
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results
  Osteoarthritis and Cartilage, 2002
• Design Issues for Conducting Cost-Effectiveness Analyses Alongside Clinical Trials
  Annual Review of Public Health, 2001
• Introducing economic and quality of life measurements into clinical studies
  Annals of Medicine, 2001
• The problem of protocol driven costs in pharmacoeconomic analysis.
  PharmacoEconomics, 1998
• Initial Antidepressant Choice in Primary Care
  JAMA, 1996
• Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugs
  Journal of Clinical Epidemiology, 1995
• A randomized trial to assess effectiveness and cost in clinical practice: Rationale and design of the cholesterol reduction intervention study (CRIS)
  Controlled Clinical Trials, 1995
• Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
  International Journal of Technology Assessment in Health Care, 1991